DeepMed Research

The Chinese University of Hong Kong

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1963-01-01

Employees: -

Market Cap: -

Website: http://www.cuhk.edu.hk

Clinical Trials

Low-magnitude High-frequency Vibration Study on Fracture Rate in Community Elderly

Phase 2

Completed

Conditions: Fractures

Interventions: Device: Low-magnitude high-frequency vibration treatment

First Posted Date: 2009-09-09

Last Posted Date: 2012-04-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 704

Registration Number: NCT00973167

Locations: 🇨🇳
Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, China

The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition

Phase 4

Completed

Conditions: Cardiovascular Disease
Renal Failure
ESRD

Interventions: Other: double-chamber bag Stay-Safe Balance system
Other: glucose-based dialysis solution

First Posted Date: 2009-08-27

Last Posted Date: 2014-09-08

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 68

Registration Number: NCT00966615

Locations: 🇭🇰
Department of Medicine & Therapeutics, Prince of Wales Hospital, Sha Tin, Hong Kong

Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study

Conditions: Epilepsy

Interventions: Drug: topiramate

First Posted Date: 2009-08-11

Last Posted Date: 2009-08-11

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 50

Registration Number: NCT00956696

Locations: 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong

Gastric Functions & Proton Pump Inhibitor( PPI) Study

Phase 4

Completed

Conditions: Functional Dyspepsia

Interventions: Drug: Placebo
Drug: Esomeprazole

First Posted Date: 2009-08-04

Last Posted Date: 2019-02-01

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 155

Registration Number: NCT00951431

Locations: 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong

PEARL Program: Empowerment Program for Patients With Type 2 Diabetes (HK4)

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Usual Care
Behavioral: Patient Peer Support and Empowerment

First Posted Date: 2009-08-03

Last Posted Date: 2015-08-25

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 632

Registration Number: NCT00950716

Locations: 🇨🇳
Asia Diabetes Foundation, Hong Kong, China

Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma

Completed

Conditions: Hepatitis B Virus

First Posted Date: 2009-06-03

Last Posted Date: 2009-06-03

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 1018

Registration Number: NCT00912847

A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy

Not Applicable

Terminated

Conditions: Diabetes Mellitus
Chronic Kidney Disease
Anemia

Interventions: Drug: Darbepoetin alfa

First Posted Date: 2009-05-22

Last Posted Date: 2009-05-22

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 16

Registration Number: NCT00907608

Locations: 🇨🇳
Prince of Wales Hospital, Hong Kong, China

The Chinese University of Hong Kong Early Arthritis Study

Not Applicable

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Methotrexate
Drug: Infliximab

First Posted Date: 2009-05-14

Last Posted Date: 2012-08-02

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 40

Registration Number: NCT00901550

Locations: 🇨🇳
The Prince of Wales Hospital, Hong Kong, China
🇨🇳
Prince of Wales Hospital, Hong Kong, China
🇨🇳
Department of Medicine and Therapeutics, Hong Kong, China

Effect of Electroacupuncture in Patients With Irritable Bowel Syndrome

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Device: Electroacupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))
Device: Sham acupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))

First Posted Date: 2009-05-13

Last Posted Date: 2009-07-02

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 42

Registration Number: NCT00900965

Locations: 🇨🇳
The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China

Aliskiren for Immunoglobulin A (IgA) Nephropathy

Phase 3

Completed

Conditions: IgA Nephropathy

Interventions: Drug: Aliskiren
Drug: Placebo

First Posted Date: 2009-03-27

Last Posted Date: 2012-12-04

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 22

Registration Number: NCT00870493

Locations: 🇭🇰
Prince of Wales Hospital, Shatin, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy